Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Clinical Lymphoma, Myeloma & Leukemia|August 11, 2014
Radiation therapy is an effective modality in the treatment of mantle cell lymphoma, even in heavily pretreated patientsWaqar Haque, K Ranh Voong, Ferial Shihadeh, et al.
Practical Radiation Oncology|July 2, 2018
Preoperative contralateral lung radiation dose is associated with postoperative pulmonary toxicity in patients with locally advanced non-small cell lung cancer treated with trimodality therapyWenji Guo, Xuan Hui, Salem Alfaifi, et al.
American Journal of Clinical Oncology|August 4, 2015
Chemoradiation for High-grade Neuroendocrine Carcinoma of the Rectum and Anal CanalK Ranh Voong, Asif Rashid, Christopher H Crane, et al.
Advances in Radiation Oncology|April 3, 2023
Improving Quality Metrics in Radiation Oncology: Implementation of Pretreatment Peer Review for Stereotactic Body Radiation Therapy in Patients with Thoracic CancerCarmen Kut, Leslie Chang, Russell K Hales, et al.
Practical Radiation Oncology|March 24, 2020
Exploring the Relationship of Radiation Dose Exposed to the Length of Esophagus and Weight Loss in Patients with Lung CancerPeijin Han, Russell Hales, Pranav Lakshminarayanan, et al.
Advances in Radiation Oncology|November 9, 2017
Long-term economic value of hypofractionated prostate radiation: Secondary analysis of a randomized trialK Ranh Voong, Lincy S Lal, Deborah A Kuban, et al.
JCO Clinical Cancer Informatics|September 2, 2021
Improving Early Identification of Significant Weight Loss Using Clinical Decision Support System in Lung Cancer Radiation TherapyPeijin Han, Sang Ho Lee, Kazumasa Noro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2018
Randomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) Versus Conventionally Fractionated IMRT for Localized Prostate CancerKaren E Hoffman, K Ranh Voong, Lawrence B Levy, et al.
Clinical Lung Cancer|August 31, 2022
Definitive Chemoradiation and Durvalumab Consolidation for Locally Advanced, Unresectable KRAS-mutated Non-Small Cell Lung CancerMatthew Z Guo, Joseph C Murray, Paola Ghanem, et al.
Thoracic Cancer|October 15, 2021
Trimodality therapy for esophageal cancer: The role of surgical and radiation treatment parameters in the development of anastomotic complicationsSalem Alfaifi, Robert Chu, Xuan Hui, et al.
Pageof 3